Key Metrics
CiteScore 

7
SNIP 

1
Recommended pre-submission checks
Powered by 

Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | Wiley-Blackwell |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2200 |
| Publication Time | 8 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | The Alzheimer's Association |
| Frequency | Continuous publication |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
Identification of cognitive impairment using the Lancet Commission's risk factors and Medicare administrative data
- 12 May 2026
- Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Interchangeability of CSF and PET to identify Alzheimer's disease pathology
- 12 May 2026
- Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Application of machine learning to blood‐based biomarkers of Alzheimer's disease in Down syndrome
- 6 Apr 2026
- Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Incremental value of plasma biomarkers in predicting clinical decline among cognitively unimpaired older adults: Results from the A4 trial
- 3 Apr 2026
- Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
The influence of bilingualism on the assessment and treatment of an Italian–English speaker with the logopenic variant of PPA
- 2 Apr 2026
- Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
The relative contribution of modifiable and non-modifiable factors for determining cognition in mid-life individuals at risk for late-life Alzheimer's disease.
- 1 Apr 2026
- Alzheimer's & dementia (Amsterdam, Netherlands)
Identification of cognitive impairment using the Lancet Commission's risk factors and Medicare administrative data
- 12 May 2026
- Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Interchangeability of CSF and PET to identify Alzheimer's disease pathology
- 12 May 2026
- Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Application of machine learning to blood‐based biomarkers of Alzheimer's disease in Down syndrome
- 6 Apr 2026
- Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Incremental value of plasma biomarkers in predicting clinical decline among cognitively unimpaired older adults: Results from the A4 trial
- 3 Apr 2026
- Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
The influence of bilingualism on the assessment and treatment of an Italian–English speaker with the logopenic variant of PPA
- 2 Apr 2026
- Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
The relative contribution of modifiable and non-modifiable factors for determining cognition in mid-life individuals at risk for late-life Alzheimer's disease.
- 1 Apr 2026
- Alzheimer's & dementia (Amsterdam, Netherlands)